The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms
- 3 July 2022
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 366, 26-32
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Antivenoms for the treatment of snakebite envenomings: The road aheadBiologicals, 2011
- Regional divergence of phospholipase A2-like protein cDNAs between New Guinean and Australian Pseudechis australisToxicon, 2010
- The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and DeathsPLOS Medicine, 2008
- Snake Venomics of Bitis Species Reveals Large Intragenus Venom Toxin Composition Variation: Application to Taxonomy of Congeneric TaxaJournal of Proteome Research, 2007
- Snake Venomics ofBitis gabonica gabonica. Protein Family Composition, Subunit Organization of Venom Toxins, and Characterization of Dimeric Disintegrins Bitisgabonin-1 and Bitisgabonin-2Journal of Proteome Research, 2006
- Anticoagulant proteins from snake venoms: structure, function and mechanismBiochemical Journal, 2006
- Collett's snake (Pseudechis colletti) envenoming in snake handlersQJM: An International Journal of Medicine, 2006
- Structure–function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venomsToxicon, 2005
- Targeting of Venom Phospholipases: The Strongly Anticoagulant Phospholipase A2 from Naja nigricollis Venom Binds to Coagulation Factor Xa to Inhibit the Prothrombinase ComplexArchives of Biochemistry and Biophysics, 1999
- Neurotoxicity and haemostatic disturbances in patients envenomed by the Papuan black snake (Pseudechis papuanus)Toxicon, 1994